Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study).
Saved in:
| Title: | Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson's disease: A double-blind, randomized placebo-controlled trial (Parkinson's Disease Overactive bladder Mirabegron, PaDoMi Study). |
|---|---|
| Authors: | Cho SY; Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea., Jeong SJ; Department of Urology, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea., Lee S; Department of Urology, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea., Kim J; Department of Urology and Urological Science Institute, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea., Lee SH; Department of Urology, College of Medicine, Dongtan Sacred Heart Hospital, Hallym University, Hwaseong, South Korea., Choo MS; Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, South Korea., Oh SJ; Department of Urology, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, South Korea. |
| Source: | Neurourology and urodynamics [Neurourol Urodyn] 2021 Jan; Vol. 40 (1), pp. 286-294. Date of Electronic Publication: 2021 Jan 03. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6777 (Electronic) Linking ISSN: 07332467 NLM ISO Abbreviation: Neurourol Urodyn Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1520-6777 |
|---|---|
| DOI: | 10.1002/nau.24552 |
